On the recordDecember 2, 2014
I ask unanimous consent that the bill be read a third time, passed, and the motion to reconsider be considered made and laid upon the table, with no intervening action or debate. The PRESIDING OFFICER. Without objection, it is so ordered. The bill (S. 2917) was ordered to be engrossed for a third reading, was read the third time, and passed, as follows: S. 2917 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Adding Ebola to the FDA Priority Review Voucher Program Act''. SEC. 2. PRIORITY REVIEW TO ENCOURAGE TREATMENTS FOR TROPICAL DISEASES. Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended-- (1) in subsection (a)(3)-- (A) by redesignating subparagraph (Q) as subparagraph (R); (B) by inserting after subparagraph (P) the following: ``(Q) Filoviruses.''; and (C) in subparagraph (R), as so redesignated, by striking ``regulation by'' and inserting ``order of''; and (2) in subsection (b)-- (A) in paragraph (2), by adding ``There is no limit on the number of times a priority review voucher may be transferred before such voucher is used.'' after the period at the end; and (B) in paragraph (4), by striking ``365 days'' and inserting ``90 days''. ____________________
